Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriel Nowak

Showing results (171-180 of 187) with videos related to

Pageof 19
Sort By:
Frontiers in Pharmacology|September 12, 2022
Combined hyperforin and lanicemine treatment instead of ketamine or imipramine restores behavioral deficits induced by chronic restraint stress and dietary zinc restriction in miceBartłomiej Pochwat, Paulina Misztak, Julia Masternak, et al.
Neurotoxicity Research|November 20, 2015
Alterations of Bio-elements, Oxidative, and Inflammatory Status in the Zinc Deficiency Model in RatsUrszula Doboszewska, Bernadeta Szewczyk, Magdalena Sowa-Kućma, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 28, 2007
Characterization of the antinociceptive actions of bicifadine in models of acute, persistent, and chronic painAnthony S Basile, Aaron Janowsky, Krystyna Golembiowska, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 15, 2006
The anxioselective agent 7-(2-chloropyridin-4-yl)pyrazolo-[1,5-a]-pyrimidin-3-yl](pyridin-2-yl)methanone (DOV 51892) is more efficacious than diazepam at enhancing GABA-gated currents at alpha1 subunit-containing GABAA receptorsPiotr Popik, Emmanuel Kostakis, Martyna Krawczyk, et al.
Molecular Neurobiology|December 15, 2015
Concentration-Dependent Dual Mode of Zn Action at Serotonin 5-HT1A Receptors: In Vitro and In Vivo StudiesGrzegorz Satała, Beata Duszyńska, Katarzyna Stachowicz, et al.
European Journal of Medicinal Chemistry|January 3, 2013
Antidepressant and antipsychotic activity of new quinoline- and isoquinoline-sulfonamide analogs of aripiprazole targeting serotonin 5-HT₁A/5-HT₂A/5-HT₇ and dopamine D₂/D₃ receptorsPaweł Zajdel, Krzysztof Marciniec, Andrzej Maślankiewicz, et al.
European Journal of Medicinal Chemistry|October 7, 2019
Synthesis and biological evaluation of new multi-target 3-(1H-indol-3-yl)pyrrolidine-2,5-dione derivatives with potential antidepressant effectMartyna Z Wróbel, Andrzej Chodkowski, Franciszek Herold, et al.
Nutrients|August 23, 2020
Imipramine Influences Body Distribution of Supplemental Zinc Which May Enhance Antidepressant ActionAnna Rafało-Ulińska, Ewa Poleszak, Aleksandra Szopa, et al.
European Journal of Medicinal Chemistry|August 6, 2011
Synthesis and biological investigation of potential atypical antipsychotics with a tropane core. Part 1Tomasz Słowiński, Jacek Stefanowicz, Maciej Dawidowski, et al.
European Journal of Medicinal Chemistry|August 12, 2009
Novel 4-aryl-pyrido[1,2-c]pyrimidines with dual SSRI and 5-HT1A activity: part 2Franciszek Herold, Łukasz Izbicki, Andrzej Chodkowski, et al.
Pageof 19

Showing results (171-180 of 187) with videos related to

Sort By:
Pageof 19
Frontiers in Pharmacology|September 12, 2022
Combined hyperforin and lanicemine treatment instead of ketamine or imipramine restores behavioral deficits induced by chronic restraint stress and dietary zinc restriction in miceBartłomiej Pochwat, Paulina Misztak, Julia Masternak, et al.
Neurotoxicity Research|November 20, 2015
Alterations of Bio-elements, Oxidative, and Inflammatory Status in the Zinc Deficiency Model in RatsUrszula Doboszewska, Bernadeta Szewczyk, Magdalena Sowa-Kućma, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 28, 2007
Characterization of the antinociceptive actions of bicifadine in models of acute, persistent, and chronic painAnthony S Basile, Aaron Janowsky, Krystyna Golembiowska, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 15, 2006
The anxioselective agent 7-(2-chloropyridin-4-yl)pyrazolo-[1,5-a]-pyrimidin-3-yl](pyridin-2-yl)methanone (DOV 51892) is more efficacious than diazepam at enhancing GABA-gated currents at alpha1 subunit-containing GABAA receptorsPiotr Popik, Emmanuel Kostakis, Martyna Krawczyk, et al.
Molecular Neurobiology|December 15, 2015
Concentration-Dependent Dual Mode of Zn Action at Serotonin 5-HT1A Receptors: In Vitro and In Vivo StudiesGrzegorz Satała, Beata Duszyńska, Katarzyna Stachowicz, et al.
European Journal of Medicinal Chemistry|January 3, 2013
Antidepressant and antipsychotic activity of new quinoline- and isoquinoline-sulfonamide analogs of aripiprazole targeting serotonin 5-HT₁A/5-HT₂A/5-HT₇ and dopamine D₂/D₃ receptorsPaweł Zajdel, Krzysztof Marciniec, Andrzej Maślankiewicz, et al.
European Journal of Medicinal Chemistry|October 7, 2019
Synthesis and biological evaluation of new multi-target 3-(1H-indol-3-yl)pyrrolidine-2,5-dione derivatives with potential antidepressant effectMartyna Z Wróbel, Andrzej Chodkowski, Franciszek Herold, et al.
Nutrients|August 23, 2020
Imipramine Influences Body Distribution of Supplemental Zinc Which May Enhance Antidepressant ActionAnna Rafało-Ulińska, Ewa Poleszak, Aleksandra Szopa, et al.
European Journal of Medicinal Chemistry|August 6, 2011
Synthesis and biological investigation of potential atypical antipsychotics with a tropane core. Part 1Tomasz Słowiński, Jacek Stefanowicz, Maciej Dawidowski, et al.
European Journal of Medicinal Chemistry|August 12, 2009
Novel 4-aryl-pyrido[1,2-c]pyrimidines with dual SSRI and 5-HT1A activity: part 2Franciszek Herold, Łukasz Izbicki, Andrzej Chodkowski, et al.
Pageof 19